H. Lundbeck AS (STU:LDBA) Inventories, Work In Process: €0 Mil (As of Mar. 2026)


STU:LDBA H. Lundbeck AS STU:LDBA
68 GF Score
Price €5.75
GF Value €6.36
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is H. Lundbeck AS Inventories, Work In Process?

H. Lundbeck AS STU:LDBA -2.46% 68 Inventories, Work In Process is €0 Mil as of Mar. 2026. GuruFocus rates STU:LDBA with a GF Score™ of 68/100 and a GF Value™ of €6.36 (Modestly Undervalued). The stock has 3 warning signs investors should review.

Work in process is the part of a manufacturer's inventory that is in the production process and has not yet been completed and transferred to the finished goods inventory. H. Lundbeck AS's work in process for the quarter that ended in Mar. 2026 was €0 Mil.

H. Lundbeck AS Inventories, Work In Process Historical Data

* Premium members only.

The historical data trend for H. Lundbeck AS's Inventories, Work In Process can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

H. Lundbeck AS Inventories, Work In Process Chart

H. Lundbeck AS Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Inventories, Work In Process
Get a 7-Day Free Trial Premium Member Only Premium Member Only 206.29 296.66 346.15 313.10 317.85

H. Lundbeck AS Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Inventories, Work In Process Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 317.85 0.00
STU:LDBA
68GF Score
H. Lundbeck AS STU:LDBA
Inventories, Work In Process is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

H. Lundbeck AS Inventories, Work In Process Calculation

That part of a manufacturer's inventory that is in the production process and has not yet been completed and transferred to the finished goods inventory. This account contains the cost of the direct material, direct labor, and factory overhead placed into the products on the factory floor. A manufacturer must disclose in its financial statements the cost of its work-in-process as well as the cost of finished goods and materials on hand.

What does a Inventories, Work In Process of €0 Mil mean?
H. Lundbeck AS (STU:LDBA) has a Inventories, Work In Process of €0 Mil as of Mar. 2026. Work in progress is the portion of inventory containing goods that are unfinished. View historical data on H. Lundbeck AS and its competitors.
Is H. Lundbeck AS's Inventories, Work In Process too high?
H. Lundbeck AS's current Inventories, Work In Process is €0 Mil. Overall, H. Lundbeck AS has a GF Score™ of 68/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does H. Lundbeck AS's Inventories, Work In Process compare to ZTS and UTHR?
H. Lundbeck AS's Inventories, Work In Process of €0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Work In Process for a Drug Manufacturers company?
A good Inventories, Work In Process depends on the Drug Manufacturers industry context. However, Inventories, Work In Process should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Work In Process mean?
A high Inventories, Work In Process can signal that a stock is expensive relative to its fundamentals. Work in progress is the portion of inventory containing goods that are unfinished. View historical data on H. Lundbeck AS and its competitors. H. Lundbeck AS's current Inventories, Work In Process is €0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is H. Lundbeck AS stock overvalued right now?
Based on GuruFocus' analysis, H. Lundbeck AS (STU:LDBA) is currently considered Modestly Undervalued. The stock's GF Value™ is €6.36, compared to a current price of €5.75 — trading 9.6% below its estimated fair value. The current Inventories, Work In Process is €0 Mil. H. Lundbeck AS's overall GF Score™ is 68/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Work In Process calculated?
Inventories, Work In Process is calculated from a company's financial statements. For H. Lundbeck AS (STU:LDBA), the current Inventories, Work In Process is €0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is H. Lundbeck AS (STU:LDBA) Overvalued in 2026?

Based on GuruFocus' analysis, H. Lundbeck AS stock appears to be undervalued. The current stock price of €5.75 is trading 9.6% below its estimated GF Value™ of €6.36. GuruFocus considers H. Lundbeck AS to be Modestly Undervalued.

Key valuation signals for STU:LDBA:

  • Inventories, Work In Process: €0 Mil
  • GF Value™: €6.36 vs. price of €5.75 (9.6% below fair value)
  • GF Score™: 68/100 with 3 warning signs

No single metric tells the full story. See the STU:LDBA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

H. Lundbeck AS Business Description

Address Ottiliavej 9, Valby, DNK, 2500
Lundbeck is a Denmark-based pharmaceutical firm that focuses on the development and commercialization of central nervous system drugs including antidepressants, antipsychotics, and antiepileptic products. The company's portfolio includes Abilify Maintena and Rexulti for psychosis, Brintellix/Trintellix for depression, Northera for Parkinson's disease symptoms, Sabril and Onfi for seizures, and Vyepti for migraine prevention. Most of the company's sales are derived in North America, followed by Asia and Europe.
68GF Score

Get the complete analysis for STU:LDBA

Inventories, Work In Process is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€5.75
Price
€6.36
GF Value